Research Paper Volume 12, Issue 15 pp 15222—15259
Global variability of the human IgG glycome
- 1 Genos Glycoscience Research Laboratory, Zagreb, Croatia
- 2 Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy
- 3 Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
- 4 Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China
- 5 School of Medical and Health Sciences, Edith Cowan University, Perth, Australia
- 6 Institute for Anthropological Research, Zagreb, Croatia
- 7 Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom
- 8 School of Medicine, University of Split, Split, Croatia
- 9 Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA
- 10 Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA
- 11 Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
- 12 Department of Oncology, Koç University School of Medicine, Istanbul, Turkey
- 13 Careggi University Hospital, Florence, Italy
- 14 School of Population Health and Environmental Sciences, King's College London, London, United Kingdom
- 15 MRC Human Genetics Unit, MRC Institute for Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom
- 16 Makerere University Walter Reed Project, Kampala, Uganda
- 17 Institute of Clinical Biochemistry, Priština, Kosovo
- 18 St. Catherine Hospital, Zagreb, Croatia
- 19 Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- 20 Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
- 21 Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom
- 22 Institute of Cardiovascular Science, Faculty of Population Health Sciences, London, United Kingdom
- 23 Department of Forensic Sciences, George Washington University, Washington, DC 20007, USA
- 24 Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia
Received: May 26, 2020 Accepted: July 25, 2020 Published: August 12, 2020
https://doi.org/10.18632/aging.103884How to Cite
Copyright © 2020 Štambuk et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Immunoglobulin G (IgG) is the most abundant serum antibody which structural characteristics and effector functions are modulated through the attachment of various sugar moieties called glycans. Composition of the IgG N-glycome changes with age of an individual and in different diseases. Variability of IgG glycosylation within a population is well studied and is known to be affected by both genetic and environmental factors. However, global inter-population differences in IgG glycosylation have never been properly addressed. Here we present population-specific N-glycosylation patterns of IgG, analyzed in 5 different populations totaling 10,482 IgG glycomes, and of IgG’s fragment crystallizable region (Fc), analyzed in 2,579 samples from 27 populations sampled across the world. Country of residence associated with many N-glycan features and the strongest association was with monogalactosylation where it explained 38% of variability. IgG monogalactosylation strongly correlated with the development level of a country, defined by United Nations health and socioeconomic development indicators, and with the expected lifespan. Subjects from developing countries had low levels of IgG galactosylation, characteristic for inflammation and ageing. Our results suggest that citizens of developing countries may be exposed to environmental factors that can cause low-grade chronic inflammation and the apparent increase in biological age.